Vertex Pharma scientist talks about the long road to developing non
WASHINGTON (AP) — For decades, patients seeking medication for pain have had two choices: over-the-counter drugs like aspirin or powerful prescription opioids like oxycodone.
Opioid prescriptions have plummeted over the last decade as doctors have become more attuned to the risks of addiction and misuse during the country’s ongoing drug epidemic.
Vertex Pharmaceuticals recently reported positive results for a non-opioid painkiller, one of several medications the Boston-based drugmaker has been developing for various forms of pain. Patients taking the drug after surgery experienced more pain relief than those getting a placebo, although the drug didn’t meet a secondary goal of outperforming treatment with an opioid.
The Associated Press spoke with Vertex’s chief scientist Dr. David Altshuler about the company’s research and development plans. The interview has been edited for length and clarity.
Related articles
Chinese cars gain popularity in Botswana
GABORONE, May 4 (Xinhua) -- At the 9th edition of the Shell Gaborone Motor Show in Gaborone, the Bot2024-05-07Flying Tigers veteran visits Great Wall in Beijing
US Flying Tigers veteran Harry Moyer (third from left), who is 102, visits the Great Wall in Beijing2024-05-07Consultation of legislation on Article 23 begins
Hong Kong will enact a new national security ordinance to address risks, Chief Executive John Lee Ka2024-05-07Interview: Expert says U.S. interest rate hikes causing ripple effects in developing countries
ABUJA, Nov. 10 (Xinhua) -- The successive U.S. rate hikes have sent shockwaves into developing count2024-05-07Zendaya wows in a glamorous vintage backless dress as she attends Anna Wintour's star
Zendaya showed off her jaw-dropping figure in a dazzling gown as she arrived at Vogue editor Anna Wi2024-05-07Roundup: Experts warn hunger, food insecurity rising in Africa
ADDIS ABABA, Oct. 11 (Xinhua) -- Hunger, food insecurity, and malnutrition are on the rise in Africa2024-05-07
atest comment